Investor Presentaiton

MenQuadfi first and only ready-to-use syringe Source: Sanofi data on file 72 Vaccines Investor Event > ~80% preference by U.S. HCPs¹ when ready-to-use syringe option is available > Unique presentation competitive advantage: no other ACWY syringe available > U.S. FDA submission in July 2023, available early 2024 sanofi

View entire presentation